Carbon tetrabromide → HCID 19851581, compound
Reaction equation
[Cl:1][C:2]1[C:7]2[C:8](=[O:19])[N:9]([CH3:18])[CH2:10][C:11]3[N:12]([CH:13]=[N:14][C:15]=3[CH:16]=O)[C:6]=2[CH:5]=[CH:4][CH:3]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[Br:39][C:40](Br)(Br)[Br:41]>C(Cl)Cl>[BrH:39].[Cl:1][C:2]1[C:7]2[C:8](=[O:19])[N:9]([CH3:18])[CH2:10][C:11]3[N:12]([CH:13]=[N:14][C:15]=3[CH:16]=[C:40]([Br:41])[Br:39])[C:6]=2[CH:5]=[CH:4][CH:3]=1Participants
Procedure
3.0 g (10.9 mmol) of 7-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxaldehyde and 5.7 g (21.7 mmol) of triphenylphosphine were dissolved in 80 ml of methylene chloride at room temperature. Thereafter, the mixture was cooled with an ice-bath to 0° and at this temperature there was added dropwise thereto a solution of 4.0 g (12.0 mmol) of tetrabromomethane in 15 ml of methylene chloride. Thereafter, the mixture was stirred at room temperature for a further 6 hours and subsequently evaporated in a vacuum. The residue was suspended in ethyl acetate and heated under reflux for 30 minutes, cooled to 10° while stirring, suction filtered and dried. The crystalline crude product was recrystallized from alcohol and there was obtained 7-chloro-3-(2,2-dibromovinyl)-4,5-dihydro-5-methyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one hydrobromide as white crystals of melting point 215°-217°.
Workup
- temperatureThereafter, the mixture was cooled with an ice-bath to 0° and at this temperature there
- additionwas added dropwise
- customsubsequently evaporated in a vacuum
- temperatureheated
- temperatureunder reflux for 30 minutes
- temperaturecooled to 10°
- stirringwhile stirring
- filtrationsuction filtered
- customdried
- customThe crystalline crude product was recrystallized from alcohol
Sources & evidence
- ORD record
- ord-3ccfc75f1c5f4c8f84166765418457e3
- Source dataset
- uspto-grants-1989_09
- Patent number
- US04863920
Reaction notes
Loading…